Sotyktu

Active Ingredient(s): Deucravacitinib
FDA Approved: * September 9, 2022
Pharm Company: * BRISTOL-MYERS SQUIBB
Category: Immunosuppressive
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Sotyktu 6 mg Oral Tablet, Film Coated
NDC: 0003-0895
Labeler:
E.r. Squibb & Sons, L.L.C.